Medicare Enrolled
Dr. Richard Maggio, M.D.
Optician · Staten Island, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maggio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maggio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maggio
Dr. Richard Maggio is an optician specialist in Staten Island, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maggio performed 1,467 Medicare services across 1,078 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maggio received a total of $5,074 from 35 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maggio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in NY
$5,074 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,467
Medicare services
Top 43% in NY for optician
1,078
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
516 | $105 | $222 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
127 | $2 | $5 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
103 | $38 | $116 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $64 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
69 | $210 | $462 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
67 | $0 | $1 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
62 | $78 | $220 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
59 | $119 | $308 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
51 | $47 | $2,470 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
49 | $85 | $270 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
42 | $30 | $335 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
40 | $332 | $1,740 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
36 | $6 | $75 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
33 | $46 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $11 | $40 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
25 | $178 | $800 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $53 | $94 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
18 | $160 | $607 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
18 | $5 | $14 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $188 | $3,385 |
| Incision of sperm-producing gland A procedure involving an incision or puncture into a gland that produces fluid to facilitate sperm movement. |
11 | $388 | $2,096 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,074
Total received (2018-2024)
Avg $725/year across 7 years
Top 23% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
166
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,644 (91.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$429 (8.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,028
2023
$1,067
2022
$740
2021
$383
2020
$259
2019
$205
2018
$391
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$1,281
Tolmar, Inc.
$204
PROCEPT BioRobotics Corporation
$156
ABBVIE INC.
$97
Bayer Healthcare Pharmaceuticals Inc.
$82
Axonics, Inc.
$72
Janssen Biotech, Inc.
$51
Astellas Pharma US Inc
$30
Boston Scientific Corporation
$24
Olympus America Inc.
$18
Ferring Pharmaceuticals Inc.
$13
Top 3 companies account for 80.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$1,458
Astellas Pharma US Inc
$534
Janssen Biotech, Inc.
$436
PROCEPT BioRobotics Corporation
$419
Axonics, Inc.
$256
MERZ NORTH AMERICA, INC.
$233
Tolmar, Inc.
$204
ABBVIE INC.
$198
Bayer Healthcare Pharmaceuticals Inc.
$178
UroGen Pharma, Inc.
$128
Rochester Medical Corporation
$122
180 Medical, Inc.
$113
Endo Pharmaceuticals Inc.
$68
PFIZER INC.
$67
UROVANT SCIENCES INC
$66
Progenics Pharmaceuticals, Inc.
$65
Bayer HealthCare Pharmaceuticals Inc.
$64
Boston Scientific Corporation
$56
C. R. BARD, INC. & SUBSIDIARIES
$49
Galderma Laboratories, L.P.
$43
Merz North America, Inc.
$40
Antares Pharma, Inc.
$36
Allergan, Inc.
$27
Medtronic USA, Inc.
$24
DENTSPLY IH AB
$23
Allergan Inc.
$21
Myovant Sciences Inc.
$19
Hollister Incorporated
$19
Olympus America Inc.
$18
Aytu BioScience, Inc
$18
Dendreon Pharmaceuticals LLC
$17
Medtronic, Inc.
$15
ROCHESTER MEDICAL CORPORATION
$14
Ferring Pharmaceuticals Inc.
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · BOTOX · BOTOX THERAPEUTIC · Bulkamid · ELIGARD · ERLEADA · GEMTESA · GENERAL THERAPIES · GENTLECATH · INTERSTIM · JELMYTO · KEYTRUDA · LoFric · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · UROLIFT · VaPro Plus Pocket · XIAFLEX · XTANDI · Xofigo · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
13,520
Per 100K population
2743.9
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maggio is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maggio experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maggio performed 516 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maggio receive payments from pharmaceutical companies?
Yes. Dr. Maggio received a total of $5,074 from 35 companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maggio's costs compare to other opticians in Staten Island?
Dr. Maggio's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maggio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Staten Island
Browse opticians in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology